Our team has over 100 years of experience in healthcare.

 
 
 

John Daniel – Chief Executive Officer

John has worked in the tissue transplant field for nearly 25 years and has been influential as a leader and innovator. In working with many start-up companies, he’s participated in several mergers, acquisitions and IPOs. John accepted his first executive position, Executive Director at Tutogen Medical, at age 28. He has played a significant role developing and launching new technologies across many different surgical applications. In 2002, John created a consultancy business to aid companies in maintaining compliance with FDA regulations. John’s second company, Surgical Biologics, founded in 2006, created a new type of biologic implant derived from donated placental tissue. These products were the first of their kind, and are still considered the gold standard of placental based products. Surgical Biologics was sold to MiMedx Group (MDXG) in 2011, and using mostly Surgical Biologics’ products, MiMedx has grown to over a $1 Billion market cap. John has been granted 26 patents related to Human Cell and Tissue based Products (HCT/P) from the US Patent and Trademark Office, with more applications pending with the USPTO, including several applications assigned to StimLabs. Before starting his career in the tissue transplant industry, John served in United States Marine Corp.

 

Bob Milani – Vice President of Sales

Bob has 22 years in sales and sales management experience in the disciplines of spine surgery, neurosurgery, cranio-maxillofacial and peripheral vascular.  Bob spent 16 years with Zimmer Biomet Spine, where he held positions as Commercial Leader for Canada & Latin America, Vice President of U.S. Sales and Southeast Area Vice President.   He has a passion for training and developing sales professionals and leaders.  Bob was instrumental in the development of the Zimmer Enhancing Sales Talent (ZEST) training modules and has led multiple sales training, sales management and leadership courses.  Prior to entering the medical device field in 1995, Bob served 12 years in the U.S. Army as an infantry officer.  The highlight of his military career was the command of two infantry companies:  The first, in Korea at the demilitarized zone, and the second, in ‘The Old Guard’The U.S. Army’s Official Ceremonial Unit and Escort to the President at Fort Myer and Arlington Cemetery, Virginia.   Bob has a Bachelor of Science degree from Old Dominion University, Norfolk, Virginia, and is a graduate of the Defense Information School (DINFOS) for Public Affairs and Journalism.  Bob is also a graduate of the U.S. Army’s Combined Arms Services Staff School, Airborne, Air Assault and Ranger schools.

 
person.jpg

Sarah Griffiths Langbord PhD – Vice President of Product Development

Dr. Griffiths has over 12 years of experience in tissue engineering and regeneration medicine. Before joining StimLabs, Sarah was the Global Technical Application Scientist for the Cell Therapy Group at Irvine Scientific. As a founding member, Dr. Griffiths not only helped to develop the cell therapy business but was also responsible for fully characterized justifications on new product ideas and market assessments for proposed products. At the Georgia Institute of Technology Sarah was a Senior Research Scientist within the Stem Cell Engineering Centre. Prior to that she performed post-doctoral research as part of the NSF Science & Technology Center, EBICS and in collaboration with the Emory Personalized Immunotherapy Center. Sarah holds a Ph.D. in Medical Devices and Bioengineering from the University of Strathclyde, Glasgow and a master’s degree in Mechanical Engineering from Brunel University, London. Dr. Griffiths has published 9 peer reviewed journal articles and has several applications pending with the USPTO related to Human Cell and Tissue based Products (HCT/P). During 2014-2015, Sarah served as a committee member on the Process and Product Development sub-committee for the International Society for Cellular Therapy. Sarah joined StimLabs in November 2015.

 
 

Melissa Gaynor O’Connor – Vice President of Quality Assurance & Regulatory Affairs

Melissa Gaynor O’Connor, M.S., RAC has 16 years of experience in medical device, combination product, and human tissue new product development research, engineering, and commercialization. She has over 5 years of experience in Quality System design, implementation, maintenance, and compliance. Prior to joining StimLabs, Melissa held Quality leadership positions serving as the Management Representative, Head of Quality, and Official FDA correspondent for prescription eye-glass lens manufacturer QSpex Technologies, Inc., and Chemence Medical Products, Inc., a global manufacturer of adhesive based Class II medical devices for wound closure. During her 11 year tenure with Kimberly-Clark Health Care, Melissa held positions in Regulatory Affairs, Product Development, and Process Engineering. In addition to Quality Systems expertise, Melissa is skilled at developing comprehensive regulatory strategies to support new product development including pre-market approval requirements for the U.S and E.U. She is a member of the Regulatory Affairs Professional Society (RAPS) and holds an active RAC certification. Melissa holds a BS degree in Biological Sciences from the University of Georgia and a MS Degree from the University of Georgia School of Pharmacy in Biomedical and Pharmaceutical Regulatory Affairs. Melissa joined StimLabs in February 2016.

 

Kristina Seracen – Vice President of Reimbursement Operations

Kristina Seracen, MA, CPC has over 11 years of experience in healthcare reimbursement and has worked in the regenerative medicine space for the past 8 years. She held reimbursement leadership positions at Advanced BioHealing, Shire Regenerative Medicine and Osiris Therapeutics. Kristina is a key reimbursement content expert; understanding the complex buy and bill environment across multiple settings of care. In addition to her reimbursement expertise, Kristina is skilled at payer communication, research, business development, and sales coordination. Kristina joined StimLabs in August 2016 as the Vice President of Reimbursement Operations. She will continue to work closely with StimLabs department leaders to identify reimbursement payment challenges and opportunities for all StimLabs product lines. Kristina is responsible for all strategic planning related to coverage, coding, and reimbursement for patients and providers on current and future StimLabs products. 

 
person.jpg

Chas Harris – Director of Marketing

After graduating from the University of South Carolina with a double major in Finance and Marketing, Chas started his healthcare career in 2010 with a start-up company in the minimally invasive spine surgery market. In his sales and marketing capacities, Chas expanded the company’s global presence by developing international distribution networks, training surgeons, and launching new products in ten European and Latin American markets. In 2012, Chas joined Mölnlycke Health Care where he managed a range of innovative products across both surgical and wound care divisions of the organization, including the fastest growing line of advanced wound care products. Chas joined StimLabs in June 2016 to help bring multiple regenerative biologic products to market. 

 
 

Caroline Keel – Accounting Manager

After graduating with her B.A. of Accounting from the University of Alabama, Caroline began her career as a staff accountant at the Intersect Group. She assisted with, and eventually managed all financial and accounting procedures for the company. In 2012 she served as Senior Accountant for Emory University, further expanding her knowledge of accounting practices in large organizations. Caroline played a vital role in the inception of StimLabs. Currently, she serves as Accounting Manager and a key decision maker for many sides of the business.  

 


 
 

Learn more about how StimLabs is revolutionizing the amniotic tissue market.